Proposed Data Collection Submitted for Public Comment and Recommendations, 22052-22053 [2021-08576]
Download as PDF
<![CDATA[
22052
Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices
Centers for Disease Control and
Prevention
[60Day–21–1268; Docket No. CDC–2021–
0043]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Drug Overdose Surveillance and
Epidemiology’’. This information
collection is designed to improve local,
state, and regional situational awareness
of drug, opioid, heroin, and stimulant
overdose trends and respond to acute
local and multi-state drug outbreaks.
DATES: CDC must receive written
comments on or before June 25, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0043 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
SUMMARY:
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
VerDate Sep<11>2014
18:01 Apr 23, 2021
Jkt 253001
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Drug Overdose Surveillance and
Epidemiology (DOSE) (OMB Control No.
0920–1268, Exp. 8/31/2022)—
Extension—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The rapid increase in opioid overdose
deaths since 2013, numerous severe
fentanyl and fentanyl analog outbreaks
occurring since 2015 across the United
States, and the declaration of the opioid
overdose epidemic as a national public
health emergency on October 26, 2017
have highlighted the urgent need to
rapidly establish and enhance timely
surveillance of suspected drug, opioid,
heroin, and stimulant overdoses. These
data are critical to inform timely local,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
state, and regional response, especially
to acute and/or widespread multi-state
outbreaks.
This data collection effort, an
essential component toward reducing
the opioid crisis, is one of the top
priorities for HHS. Drug Overdose
Surveillance and Epidemiology (DOSE)
data is critical to our ability to rapidly
identify outbreaks and provide
situational awareness of changes in
emergency department (ED) visits
involving suspected drug, opioid,
heroin and stimulant overdoses at the
local, state, and regional level. This will
be accomplished by standardizing and
enhancing the sharing of existing ED
data collected by 52 health departments
(all 50 state health departments, the
health department of Puerto Rico, and
the health department of the District of
Columbia) with CDC. In addition, CDC
leadership communicates with HHS on
an ongoing basis, and this data is part
of its request to better monitor, plan,
and implement programs to prevent
overdose and reduce subsequent harm.
DOSE proposes to fund 52 health
departments (50 state health
departments, the health department of
Puerto Rico and the health department
of the District of Columbia) to rapidly
share existing ED data on counts of ED
visits involving suspected drug, opioid,
heroin, and stimulant overdoses using
two standard data forms (i.e., the Rapid
ED overdose data form and the ED
discharge overdose data form), and
standard CDC case definitions.
The system will leverage ED
syndromic data and hospital discharge
data on ED visits already routinely
collected by state and territorial health
departments. No new data will be
systematically collected from EDs, and
health departments will be reimbursed
by CDC for the burden related to sharing
ED data with CDC. Fifty-two funded
health departments (50 state health
departments, Puerto Rico, and the
District of Columbia) will rapidly share
existing ED data with CDC on a monthly
basis using the Rapid ED overdose data
form and standard CDC case definitions.
Although data may come from different
local ED data systems, it is expected to
cover at least 75% of ED visits in the
jurisdiction (e.g., state).
CDC will require all participating
health departments to provide counts of
ED visits involving suspected drug,
opioid, heroin, and stimulant overdoses
by county, age group, sex, and time (i.e.,
month and year) in a standardized
manner, using the Rapid ED overdose
data form, which is an Excel data
template. This form also collects data
quality indicators such as percentage of
ED visits missing data on key variables
E:\FR\FM\26APN1.SGM
26APN1
22053
Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices
(i.e., metadata). In order to assess and
improve rapid ED data sharing, all 52
participating health departments will
also be asked to share counts of ED
visits involving suspected drug, opioid,
heroin and stimulant overdoses by
data form, and standard CDC case
definitions. The total estimated annual
burden hours are 1,272. There are no
costs to the respondents other than their
time.
county, age group, sex, and time (i.e.,
month and year), from more finalized
hospital discharge files. The data will be
shared with CDC on a quarterly or
yearly basis using a standardized Excel
data form, the ED discharge overdose
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Total number
of responses
per
respondent
Average
burden per
response
(hours)
Total annual
burden
(hours)
Type of respondent
Form name
Participating health departments
sharing aggregate data from local
syndromic or hospital discharge
file.
Participating health departments
sharing case-level ED data with
CDC through the NSSP BioSense
(OMB #0920–0824) *.
Participating health department sharing finalized hospital discharge
data on a quarterly basis.
Participating health department sharing finalized hospital discharge
data on a yearly basis.
Rapid ED overdose data form .........
19
12
3
684
Rapid ED overdose data form .........
33
12
30/60
198
ED discharge overdose data form ...
26
4
3
312
ED discharge overdose data form ...
26
1
3
78
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–08576 Filed 4–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
18:01 Apr 23, 2021
Jkt 253001
Dan
Hartley, Ed.D., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational
Safety and Health, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26505, Telephone: (304) 285–
5812; DHartley@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
FOR FURTHER INFORMATION CONTACT:
Centers for Disease Control and
Prevention
VerDate Sep<11>2014
RFA–OH–20–007, National Center of
Excellence for the Prevention of
Childhood Agricultural Injury.
Date: June 8, 2021.
Time: 1:00 p.m.–3:00 p.m., EDT.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–08551 Filed 4–23–21; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21EL; Docket No. CDC–2021–
0041]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Learning Community for
HIV CBO Leadership Evaluation. The
purpose of this data collection is to
evaluate the National Learning
Community for HIV CBO Leadership
which is a component of cooperative
agreement CDC–RFA–PS19–1904:
Capacity Building Assistance (CBA) for
High Impact HIV Prevention Program
Integration.
DATES: CDC must receive written
comments on or before June 25, 2021.
SUMMARY:
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 86, Number 78 (Monday, April 26, 2021)]
[Notices]
[Pages 22052-22053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08576]
[[Page 22052]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-1268; Docket No. CDC-2021-0043]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Drug Overdose Surveillance and
Epidemiology''. This information collection is designed to improve
local, state, and regional situational awareness of drug, opioid,
heroin, and stimulant overdose trends and respond to acute local and
multi-state drug outbreaks.
DATES: CDC must receive written comments on or before June 25, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0043 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No.
0920-1268, Exp. 8/31/2022)--Extension--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The rapid increase in opioid overdose deaths since 2013, numerous
severe fentanyl and fentanyl analog outbreaks occurring since 2015
across the United States, and the declaration of the opioid overdose
epidemic as a national public health emergency on October 26, 2017 have
highlighted the urgent need to rapidly establish and enhance timely
surveillance of suspected drug, opioid, heroin, and stimulant
overdoses. These data are critical to inform timely local, state, and
regional response, especially to acute and/or widespread multi-state
outbreaks.
This data collection effort, an essential component toward reducing
the opioid crisis, is one of the top priorities for HHS. Drug Overdose
Surveillance and Epidemiology (DOSE) data is critical to our ability to
rapidly identify outbreaks and provide situational awareness of changes
in emergency department (ED) visits involving suspected drug, opioid,
heroin and stimulant overdoses at the local, state, and regional level.
This will be accomplished by standardizing and enhancing the sharing of
existing ED data collected by 52 health departments (all 50 state
health departments, the health department of Puerto Rico, and the
health department of the District of Columbia) with CDC. In addition,
CDC leadership communicates with HHS on an ongoing basis, and this data
is part of its request to better monitor, plan, and implement programs
to prevent overdose and reduce subsequent harm.
DOSE proposes to fund 52 health departments (50 state health
departments, the health department of Puerto Rico and the health
department of the District of Columbia) to rapidly share existing ED
data on counts of ED visits involving suspected drug, opioid, heroin,
and stimulant overdoses using two standard data forms (i.e., the Rapid
ED overdose data form and the ED discharge overdose data form), and
standard CDC case definitions.
The system will leverage ED syndromic data and hospital discharge
data on ED visits already routinely collected by state and territorial
health departments. No new data will be systematically collected from
EDs, and health departments will be reimbursed by CDC for the burden
related to sharing ED data with CDC. Fifty-two funded health
departments (50 state health departments, Puerto Rico, and the District
of Columbia) will rapidly share existing ED data with CDC on a monthly
basis using the Rapid ED overdose data form and standard CDC case
definitions. Although data may come from different local ED data
systems, it is expected to cover at least 75% of ED visits in the
jurisdiction (e.g., state).
CDC will require all participating health departments to provide
counts of ED visits involving suspected drug, opioid, heroin, and
stimulant overdoses by county, age group, sex, and time (i.e., month
and year) in a standardized manner, using the Rapid ED overdose data
form, which is an Excel data template. This form also collects data
quality indicators such as percentage of ED visits missing data on key
variables
[[Page 22053]]
(i.e., metadata). In order to assess and improve rapid ED data sharing,
all 52 participating health departments will also be asked to share
counts of ED visits involving suspected drug, opioid, heroin and
stimulant overdoses by county, age group, sex, and time (i.e., month
and year), from more finalized hospital discharge files. The data will
be shared with CDC on a quarterly or yearly basis using a standardized
Excel data form, the ED discharge overdose data form, and standard CDC
case definitions. The total estimated annual burden hours are 1,272.
There are no costs to the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Total number Average burden
Type of respondent Form name Number of of responses per response Total annual
respondents per respondent (hours) burden (hours)
----------------------------------------------------------------------------------------------------------------
Participating health Rapid ED 19 12 3 684
departments sharing aggregate overdose data
data from local syndromic or form.
hospital discharge file.
Participating health Rapid ED 33 12 30/60 198
departments sharing case- overdose data
level ED data with CDC form.
through the NSSP BioSense
(OMB #0920-0824) *.
Participating health ED discharge 26 4 3 312
department sharing finalized overdose data
hospital discharge data on a form.
quarterly basis.
Participating health ED discharge 26 1 3 78
department sharing finalized overdose data
hospital discharge data on a form.
yearly basis.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-08576 Filed 4-23-21; 8:45 am]
BILLING CODE 4163-18-P
